Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review

June 2021 | 67 pages | ID: DB4C12A2F14EN
GlobalData

Abstracts

Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Daiichi Sankyo Co Ltd (Daiichi Sankyo) is a holding company which carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompasses medicines for cardiovascular, neurological, nephrologic, diabetic, metabolic and infectious diseases, and various types of cancers. Besides cancer, the company’s other research areas include rare diseases and immune disorders. Daiichi Sankyo sells its products through its group companies, and an extensive network of medical representatives. It has operations in North America, South and Central America, Europe, and Asia. Daiichi Sankyo is headquartered in Tokyo, Japan.

Daiichi Sankyo Co Ltd Key Recent Developments

May 19,2021: Daiichi Sankyo advances science across three lead DXd ADCs with new data in multiple cancers at 2021 ASCO Virtual Meeting
May 13,2021: Daiichi Sankyo announces changes to representative directors, directors, and audit & supervisory board members
Apr 27,2021: LogicBio Therapeutics announces research collaboration with Daiichi Sankyo
Apr 05,2021: Daiichi Sankyo announces new 5-year business plan (FY2021 - FY2025)
Mar 31,2021: Pennsylvania Biotechnology Center (PABC) announces new collaboration and $10 million investment pledge from Daiichi Sankyo

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Daiichi Sankyo Co Ltd - Key Facts
Daiichi Sankyo Co Ltd - Key Employees
Daiichi Sankyo Co Ltd - Key Employee Biographies
Daiichi Sankyo Co Ltd - Major Products and Services
Daiichi Sankyo Co Ltd - History
Daiichi Sankyo Co Ltd - Company Statement
Daiichi Sankyo Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Daiichi Sankyo Co Ltd - Business Description
Business Segment: Healthcare (OTC) Products
Overview
Performance
Business Segment: Others
Performance
Business Segment: Prescription Drugs
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Daiichi Sankyo Co Ltd - Corporate Strategy
Daiichi Sankyo Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Daiichi Sankyo Co Ltd - Strengths
Daiichi Sankyo Co Ltd - Weaknesses
Daiichi Sankyo Co Ltd - Opportunities
Daiichi Sankyo Co Ltd - Threats
Daiichi Sankyo Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Daiichi Sankyo Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 19, 2021: Daiichi Sankyo advances science across three lead DXd ADCs with new data in multiple cancers at 2021 ASCO Virtual Meeting
May 13, 2021: Daiichi Sankyo announces changes to representative directors, directors, and audit & supervisory board members
Apr 27, 2021: LogicBio Therapeutics announces research collaboration with Daiichi Sankyo
Apr 05, 2021: Daiichi Sankyo announces new 5-year business plan (FY2021 - FY2025)
Mar 31, 2021: Pennsylvania Biotechnology Center (PABC) announces new collaboration and $10 million investment pledge from Daiichi Sankyo
Feb 22, 2021: Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D
Feb 22, 2021: Daiichi Sankyo appoints new corporate officers
Jan 13, 2021: New research data across DXd ADC portfolio at WCLC showcases Daiichi Sankyo’s continued commitment in lung cancer
Nov 12, 2020: Daiichi Sankyo creates new business unit to unify major oncology markets into one streamlined organization dedicated to patients with cancer
Nov 12, 2020: American Regent announces CEO transition for 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Daiichi Sankyo Co Ltd, Key Facts
Daiichi Sankyo Co Ltd, Key Employees
Daiichi Sankyo Co Ltd, Key Employee Biographies
Daiichi Sankyo Co Ltd, Major Products and Services
Daiichi Sankyo Co Ltd, History
Daiichi Sankyo Co Ltd, Subsidiaries
Daiichi Sankyo Co Ltd, Joint Venture
Daiichi Sankyo Co Ltd, Key Competitors
Daiichi Sankyo Co Ltd, Ratios based on current share price
Daiichi Sankyo Co Ltd, Annual Ratios
Daiichi Sankyo Co Ltd, Annual Ratios (Cont...1)
Daiichi Sankyo Co Ltd, Annual Ratios (Cont...2)
Daiichi Sankyo Co Ltd, Interim Ratios
Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Daiichi Sankyo Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Daiichi Sankyo Co Ltd, Performance Chart (2017 - 2021)
Daiichi Sankyo Co Ltd, Ratio Charts
Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021